223 related articles for article (PubMed ID: 34588168)
1. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
Vinogradova Y; Dening T; Hippisley-Cox J; Taylor L; Moore M; Coupland C
BMJ; 2021 Sep; 374():n2182. PubMed ID: 34588168
[TBL] [Abstract][Full Text] [Related]
2. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract][Full Text] [Related]
3. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2019 Jan; 364():k4810. PubMed ID: 30626577
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and dementia: nationwide, nested case-control study.
Pourhadi N; Mørch LS; Holm EA; Torp-Pedersen C; Meaidi A
BMJ; 2023 Jun; 381():e072770. PubMed ID: 37380194
[TBL] [Abstract][Full Text] [Related]
5. Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.
Savolainen-Peltonen H; Rahkola-Soisalo P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O; Mikkola TS
BMJ; 2019 Mar; 364():l665. PubMed ID: 30842086
[TBL] [Abstract][Full Text] [Related]
6. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
[TBL] [Abstract][Full Text] [Related]
7. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
9. Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study.
Imtiaz B; Taipale H; Tanskanen A; Tiihonen M; Kivipelto M; Heikkinen AM; Tiihonen J; Soininen H; Hartikainen S; Tolppanen AM
Maturitas; 2017 Apr; 98():7-13. PubMed ID: 28274328
[TBL] [Abstract][Full Text] [Related]
10. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.
Cordina-Duverger E; Truong T; Anger A; Sanchez M; Arveux P; Kerbrat P; Guénel P
PLoS One; 2013; 8(11):e78016. PubMed ID: 24223752
[TBL] [Abstract][Full Text] [Related]
11. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
12. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
13. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866
[TBL] [Abstract][Full Text] [Related]
14. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
15. Cognitive changes after menopause: influence of estrogen.
Henderson VW
Clin Obstet Gynecol; 2008 Sep; 51(3):618-26. PubMed ID: 18677155
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
17. Association of hormone therapy and incident gout: population-based case-control study.
Bruderer SG; Bodmer M; Jick SS; Meier CR
Menopause; 2015 Dec; 22(12):1335-42. PubMed ID: 25968834
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
Henderson VW
Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis.
Wu M; Li M; Yuan J; Liang S; Chen Z; Ye M; Ryan PM; Clark C; Tan SC; Rahmani J; Varkaneh HK; Bhagavathula AS
Pharmacol Res; 2020 May; 155():104693. PubMed ID: 32057896
[TBL] [Abstract][Full Text] [Related]
20. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
